| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |